We believe this site might serve you best:

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

SignaTECT® cAMP-Dependent Protein Kinase (PKA) Assay System Technical Bulletin

Instructions for Use of Product(s)
V7480
Literature # TB241

The most common method to assay PKA activity involves measuring the transfer of 32P-labeled phosphate to a protein or peptide substrate that is captured on phosphocellulose filters via weak electrostatic interactions. However, in the presence of multiple kinases (e.g., in a tissue extract), the 32P-labeled peptides or proteins bound to the phosphocellulose filter may reflect kinase activity other than that of PKA. To increase specificity, the SignaTECT® cAMP-Dependent Protein Kinase Assay (PKA) Assay System uses biotinylated Kemptide (LRRASLG), a peptide substrate derived from the in vivo substrate pyruvate kinase. This substrate is highly specific for PKA. The high affinity of Kemptide for PKA (Km= 5–10μM) provides sufficient sensitivity to detect the enzyme at levels typically found within most biological samples. The 32P-labeled, biotinylated substrate is recovered from the reaction mix with the SAM2® Biotin Capture Membrane, which is a novel streptavidin matrix.

Printed in USA. Revised 1/13.

Choose your country

Americas

Brazil
Canada
United States

Pacific Asia

Australia
India
Japan
Korea, Republic of
Singapore

Europe

Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Italy
Luxembourg
Netherlands
Norway
Poland
Spain
Sweden
Switzerland
United Kingdom